This webinar will focus on immunoSCAPE’s signature assay, TargetScape, to identify and profile the immune response. Dr. Simoni will overview the technology and then focus on specific case studies from recent publications.

Our presenter is Dr. Yannick Simoni, Associate-Director of Technology Development at ImmunoScape. Previously a researcher in Dr. Evan Newell’s lab at the Fred Hutch Cancer Center, Yannick is an immunologist with deep expertise in mass cytometry and multiplexing tetramer technology for identification and characterization of antigen-specific T cells in autoimmune disease and cancer.